143 related articles for article (PubMed ID: 31158749)
1. Organoantimony(III) halide complexes with azastibocine framework as potential antitumor agents: Correlation between cytotoxic activity and N→Sb inter-coordination.
Lei J; Liu Y; Ou Y; Au CT; Chen Y; Yin SF
Eur J Med Chem; 2019 Sep; 177():350-361. PubMed ID: 31158749
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines.
Islam A; Rodrigues BL; Marzano IM; Perreira-Maia EC; Dittz D; Paz Lopes MT; Ishfaq M; Frézard F; Demicheli C
Eur J Med Chem; 2016 Feb; 109():254-67. PubMed ID: 26774931
[TBL] [Abstract][Full Text] [Related]
3. Establishing the correlation between catalytic performance and N→Sb donor-acceptor interaction: systematic assessment of azastibocine halide derivatives as water tolerant Lewis acids.
Lei J; Peng L; Qiu R; Liu Y; Chen Y; Au CT; Yin SF
Dalton Trans; 2019 Jun; 48(23):8478-8487. PubMed ID: 31116205
[TBL] [Abstract][Full Text] [Related]
4. Imine-N-Heterocyclic Carbenes as Versatile Ligands in Ruthenium(II) p-Cymene Anticancer Complexes: A Structure-Activity Relationship Study.
Yang Y; Guo L; Tian Z; Liu X; Gong Y; Zheng H; Ge X; Liu Z
Chem Asian J; 2018 Oct; 13(19):2923-2933. PubMed ID: 30101417
[TBL] [Abstract][Full Text] [Related]
5. Insights into the in vitro Anticancer Effects of Diruthenium-1.
Koceva-Chyła A; Matczak K; Hikisz MP; Durka MK; Kochel MK; Süss-Fink G; Furrer J; Kowalski K
ChemMedChem; 2016 Oct; 11(19):2171-2187. PubMed ID: 27561129
[TBL] [Abstract][Full Text] [Related]
6. Significant effects of counteranions on the anticancer activity of iridium(iii) complexes.
Zhang H; Guo L; Tian Z; Tian M; Zhang S; Xu Z; Gong P; Zheng X; Zhao J; Liu Z
Chem Commun (Camb); 2018 Apr; 54(35):4421-4424. PubMed ID: 29648559
[TBL] [Abstract][Full Text] [Related]
7. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
[TBL] [Abstract][Full Text] [Related]
8. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structural characterization and biological studies of the triphenyltin(IV) complex with 2-thiobarbituric acid.
Balas VI; Verginadis II; Geromichalos GD; Kourkoumelis N; Male L; Hursthouse MB; Repana KH; Yiannaki E; Charalabopoulos K; Bakas T; Hadjikakou SK
Eur J Med Chem; 2011 Jul; 46(7):2835-44. PubMed ID: 21521629
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic and apoptotic effects of ternary silver(i) complexes bearing 2-formylpyridine thiosemicarbazones and 1,10-phenanthroline.
Silva DES; Becceneri AB; Solcia MC; Santiago JVB; Moreira MB; Gomes Neto JA; Pavan FR; Cominetti MR; Pereira JCM; Netto AVG
Dalton Trans; 2020 Apr; 49(16):5264-5275. PubMed ID: 32242564
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.
Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128
[TBL] [Abstract][Full Text] [Related]
12. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
[TBL] [Abstract][Full Text] [Related]
13. Organoantimony (III) Derivative Induces Necroptosis in Human Breast Cancer MDA-MB-231 Cells.
Liu YP; Lei J; Yin MM; Chen Y
Anticancer Agents Med Chem; 2022; 22(13):2448-2457. PubMed ID: 35040419
[TBL] [Abstract][Full Text] [Related]
14. Cationic and Neutral N-Heterocyclic Carbene Gold(I) Complexes: Cytotoxicity, NCI-60 Screening, Cellular Uptake, Inhibition of Mammalian Thioredoxin Reductase, and Reactive Oxygen Species Formation.
Zhang C; Hemmert C; Gornitzka H; Cuvillier O; Zhang M; Sun RW
ChemMedChem; 2018 Jun; 13(12):1218-1229. PubMed ID: 29603648
[TBL] [Abstract][Full Text] [Related]
15. Increasing anticancer effect in vitro and vivo of liposome-encapsulated iridium(III) complexes on BEL-7402 cells.
Zhang Y; Fei W; Zhang H; Zhou Y; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Dec; 225():111622. PubMed ID: 34624670
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of pyrrolizines and their Cu(II) complexes: Design, synthesis and cytotoxic screening with potential apoptosis-inducing activity.
Gouda AM; El-Ghamry HA; Bawazeer TM; Farghaly TA; Abdalla AN; Aslam A
Eur J Med Chem; 2018 Feb; 145():350-359. PubMed ID: 29335201
[TBL] [Abstract][Full Text] [Related]
17. Novel (S)-1,3,4,12a-tetrahydropyrazino[2,1-c][1,4]benzodiazepine-6,12(2H,11H)-dione derivatives: Selective inhibition of MV-4-11 biphenotypic B myelomonocytic leukemia cells' growth is accompanied by reactive oxygen species overproduction and apoptosis.
Mieczkowski A; Psurski M; Bagiński M; Bieszczad B; Mroczkowska M; Wilczek M; Czajkowska J; Trzybiński D; Woźniak K; Wietrzyk J
Bioorg Med Chem Lett; 2018 Feb; 28(4):618-625. PubMed ID: 29395971
[TBL] [Abstract][Full Text] [Related]
18. Diclofenac conjugates with biocides through silver(I) ions (CoMeD's); Development of a reliable model for the prediction of anti-proliferation of NSAID's-silver formulations.
Banti CN; Hatzidimitriou AG; Kourkoumelis N; Hadjikakou SK
J Inorg Biochem; 2019 May; 194():7-18. PubMed ID: 30798079
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and mechanistic studies of novel arylformylhydrazone butylphenyltin complexes as potential anticancer agents.
Jiang W; Fan S; Zhu Z; Huang H; Tan Y; Peng Y
Bioorg Chem; 2024 Aug; 149():107502. PubMed ID: 38805912
[TBL] [Abstract][Full Text] [Related]
20. Coordination environment dependence of anticancer activity in cyclometalated bismuth(III) complexes with C,O-chelating ligands.
Lei J; Liu Y; Yin M; Li S; Wang Z; Chen Y
J Inorg Biochem; 2024 Jul; 256():112571. PubMed ID: 38669912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
